FDA Hosts Rare Disease Patient Advocacy Day, Announces Meeting Details

Summary

The US Food and Drug Administration (FDA) is hosting Rare Disease Patient Advocacy Day, a meeting to discuss the needs and concerns of patients with rare diseases, and will provide updates on its efforts to address these conditions.